TriLink® CleanCap® OVA mRNA

Lieferant: TRILINK BIOTECHNOLOGIES

L-7610-100 L-7610-1000 L-7610-5
SOLUL-7610-100EA 276 CHF
SOLUL-7610-100 SOLUL-7610-1000 SOLUL-7610-5
TriLink® CleanCap® OVA mRNA
Protein- Expression Proteinexpressions-Reagenzien

Ovalbumin (OVA) is a member of the serpin superfamily and the predominant glycoprotein found in egg whites. It is a commonly used antigen for immunisation and biochemical studies and is an established model allergen for airway hyper-responsiveness.


  • Capped with CleanCap® AG cap analog, no base modifications in the sequence

  • Cap 1 structure with >95% capping efficiency for superior in vivo activity compared to Cap-0 mRNAs

  • Manufactured with TriLink’s proprietary CleanScript® method to lower dsRNA for improved performance

  • Ready to use in downstream mRNA applications and formulations

  • Grade: RUO


This mRNA is capped using CleanCap® Reagent AG, TriLink's co-transcriptional capping technology, which results in the naturally occurring Cap-1 structure with >95% capping efficiency. It is manufactured using TriLink’s CleanScript® method, polyadenylated, and optimised for mammalian systems. It mimics a fully processed mature mRNA.



CleanCap Reagent AG produces a base-modified Cap-1 mRNA, which shows superior in vivo activity compared to Cap-0 mRNA produced by legacy capping methods such as mCap or anti-reverse cap analog (ARCA).



CleanScript method is TriLink’s proprietary in vitro transcription process that is optimised to minimise dsRNA formation and increase mRNA activity in vivo.



Bitte beachten Item will be delivered at or below −40 °C and should be stored at or below −40 °C.

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR